25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Helius Medical Technologies Inc Class A
Buy, Hold or Sell?

Let's analyze Helius Medical Technologies Inc Class A together

I guess you are interested in Helius Medical Technologies Inc Class A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Helius Medical Technologies Inc Class A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Helius Medical Technologies Inc Class A

I send you an email if I find something interesting about Helius Medical Technologies Inc Class A.

1. Quick Overview

1.1. Quick analysis of Helius Medical Technologies Inc Class A (30 sec.)










1.2. What can you expect buying and holding a share of Helius Medical Technologies Inc Class A? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.02
Expected worth in 1 year
$1.19
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.17
Return On Investment
28.0%

For what price can you sell your share?

Current Price per Share
$0.61
Expected price per share
$0.373 - $0.67
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Helius Medical Technologies Inc Class A (5 min.)




Live pricePrice per Share (EOD)
$0.61
Intrinsic Value Per Share
$-30.19 - $-19.91
Total Value Per Share
$-29.17 - $-18.90

2.2. Growth of Helius Medical Technologies Inc Class A (5 min.)




Is Helius Medical Technologies Inc Class A growing?

Current yearPrevious yearGrowGrow %
How rich?$3.7m$5.4m-$1.8m-50.7%

How much money is Helius Medical Technologies Inc Class A making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$3.3m$1.1m53.3%
Net Profit Margin-2,689.2%-1,681.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Helius Medical Technologies Inc Class A (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#259 / 320

Most Revenue
#294 / 320

Most Profit
#182 / 320

Most Efficient
#311 / 320
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Helius Medical Technologies Inc Class A?

Welcome investor! Helius Medical Technologies Inc Class A's management wants to use your money to grow the business. In return you get a share of Helius Medical Technologies Inc Class A.

First you should know what it really means to hold a share of Helius Medical Technologies Inc Class A. And how you can make/lose money.

Speculation

The Price per Share of Helius Medical Technologies Inc Class A is $0.611. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Helius Medical Technologies Inc Class A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Helius Medical Technologies Inc Class A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.02. Based on the TTM, the Book Value Change Per Share is $0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.69 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Helius Medical Technologies Inc Class A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.99-161.3%-0.61-99.5%-0.83-135.5%-0.94-154.0%-1.22-199.8%
Usd Book Value Change Per Share-0.76-123.9%0.047.0%-0.69-113.7%-0.07-11.9%0.00-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.76-123.9%0.047.0%-0.69-113.7%-0.07-11.9%0.00-0.7%
Usd Price Per Share0.56-3.85-2.56-4.37-3.94-
Price to Earnings Ratio-0.14--2.41--0.65--1.26--1.17-
Price-to-Total Gains Ratio-0.74--25.02--5.75--7.46--3.96-
Price to Book Ratio0.55-5.96-2.92-3.23--3.44-
Price-to-Total Gains Ratio-0.74--25.02--5.75--7.46--3.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.611
Number of shares1636
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.04-0.07
Usd Total Gains Per Share0.04-0.07
Gains per Quarter (1636 shares)69.88-118.71
Gains per Year (1636 shares)279.52-474.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102802700-475-485
205595500-950-960
308398300-1425-1435
40111811100-1899-1910
50139813900-2374-2385
60167716700-2849-2860
70195719500-3324-3335
80223622300-3799-3810
90251625100-4274-4285
100279527900-4749-4760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%2.041.00.04.7%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%16.024.00.040.0%17.026.00.039.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.043.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%16.024.00.040.0%17.026.00.039.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Helius Medical Technologies Inc Class A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.7570.043-1872%-0.695-8%-0.073-90%-0.004-99%
Book Value Per Share--1.0161.000+2%1.525-33%1.703-40%0.911+11%
Current Ratio--3.6143.795-5%7.124-49%4.638-22%2.986+21%
Debt To Asset Ratio--0.3200.488-34%0.580-45%0.405-21%0.880-64%
Debt To Equity Ratio--0.4701.259-63%1.418-67%0.832-43%1.053-55%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--3781612.81315118080.463-75%12219522.365-69%18775123.983-80%15625686.075-76%
Eps---0.985-0.608-38%-0.828-16%-0.941-4%-1.221+24%
Ev To Ebitda Ratio---0.232-1.383+495%-2.344+909%-1.529+558%-1.077+364%
Ev To Sales Ratio--18.53730.096-38%19.937-7%43.392-57%nannan%
Free Cash Flow Per Share---0.741-0.7400%-0.7370%-0.884+19%-0.947+28%
Free Cash Flow To Equity Per Share---0.781-0.210-73%-0.704-10%-0.030-96%0.041-2008%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.013-1%
Intrinsic Value_10Y_max---19.911--------
Intrinsic Value_10Y_min---30.186--------
Intrinsic Value_1Y_max---3.226--------
Intrinsic Value_1Y_min---3.682--------
Intrinsic Value_3Y_max---8.754--------
Intrinsic Value_3Y_min---10.560--------
Intrinsic Value_5Y_max---13.152--------
Intrinsic Value_5Y_min---16.832--------
Market Cap2185058.200+4%2099612.81313800830.463-85%9158022.365-77%15646823.983-87%14639814.600-86%
Net Profit Margin---72.275-26.892-63%-16.819-77%-25.933-64%-14.126-80%
Operating Margin----15.0300%-20.2690%-26.4140%-15.5750%
Operating Ratio--80.66735.915+125%20.325+297%31.161+159%17.444+362%
Pb Ratio0.602+8%0.5535.959-91%2.917-81%3.228-83%-3.441+723%
Pe Ratio-0.155-9%-0.142-2.409+1592%-0.654+359%-1.261+785%-1.174+724%
Price Per Share0.611+8%0.5613.853-85%2.561-78%4.374-87%3.943-86%
Price To Free Cash Flow Ratio-0.206-9%-0.189-1.439+660%-0.928+390%-1.295+584%-1.122+492%
Price To Total Gains Ratio-0.807-9%-0.742-25.015+3273%-5.751+676%-7.465+907%-3.957+434%
Quick Ratio--2.6682.964-10%6.169-57%3.921-32%2.562+4%
Return On Assets---0.660-0.354-46%-0.265-60%-0.370-44%-0.401-39%
Return On Equity---0.970-0.734-24%-0.658-32%-0.656-32%-0.765-21%
Total Gains Per Share---0.7570.043-1872%-0.695-8%-0.073-90%-0.004-99%
Usd Book Value--3799000.0003618500.000+5%5452750.000-30%6097200.000-38%3192815.925+19%
Usd Book Value Change Per Share---0.7570.043-1872%-0.695-8%-0.073-90%-0.004-99%
Usd Book Value Per Share--1.0161.000+2%1.525-33%1.703-40%0.911+11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.985-0.608-38%-0.828-16%-0.941-4%-1.221+24%
Usd Free Cash Flow---2771000.000-2676249.750-3%-2636750.000-5%-3166099.950+14%-3432897.900+24%
Usd Free Cash Flow Per Share---0.741-0.7400%-0.7370%-0.884+19%-0.947+28%
Usd Free Cash Flow To Equity Per Share---0.781-0.210-73%-0.704-10%-0.030-96%0.041-2008%
Usd Market Cap2185058.200+4%2099612.81313800830.463-85%9158022.365-77%15646823.983-87%14639814.600-86%
Usd Price Per Share0.611+8%0.5613.853-85%2.561-78%4.374-87%3.943-86%
Usd Profit---3686000.000-2214749.750-40%-3395750.000-8%-3239999.950-12%-3536304.025-4%
Usd Revenue--51000.000125500.000-59%198000.000-74%156750.000-67%123950.000-59%
Usd Total Gains Per Share---0.7570.043-1872%-0.695-8%-0.073-90%-0.004-99%
 EOD+5 -3MRQTTM+9 -26YOY+6 -295Y+9 -2610Y+15 -20

3.3 Fundamental Score

Let's check the fundamental score of Helius Medical Technologies Inc Class A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.155
Price to Book Ratio (EOD)Between0-10.602
Net Profit Margin (MRQ)Greater than0-72.275
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.668
Current Ratio (MRQ)Greater than13.614
Debt to Asset Ratio (MRQ)Less than10.320
Debt to Equity Ratio (MRQ)Less than10.470
Return on Equity (MRQ)Greater than0.15-0.970
Return on Assets (MRQ)Greater than0.05-0.660
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Helius Medical Technologies Inc Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.484
Ma 20Greater thanMa 500.526
Ma 50Greater thanMa 1000.530
Ma 100Greater thanMa 2000.654
OpenGreater thanClose0.660
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Helius Medical Technologies Inc Class A

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Fundamental data was last updated by Penke on 2024-11-14 19:48:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Helius Medical Technologies Inc Class A earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Helius Medical Technologies Inc Class A to the Medical Devices industry mean.
  • A Net Profit Margin of -7,227.5% means that $-72.27 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Helius Medical Technologies Inc Class A:

  • The MRQ is -7,227.5%. The company is making a huge loss. -2
  • The TTM is -2,689.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,227.5%TTM-2,689.2%-4,538.3%
TTM-2,689.2%YOY-1,681.9%-1,007.3%
TTM-2,689.2%5Y-2,593.3%-95.9%
5Y-2,593.3%10Y-1,412.6%-1,180.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,227.5%-6.4%-7,221.1%
TTM-2,689.2%-15.2%-2,674.0%
YOY-1,681.9%-15.4%-1,666.5%
5Y-2,593.3%-18.1%-2,575.2%
10Y-1,412.6%-22.9%-1,389.7%
4.3.1.2. Return on Assets

Shows how efficient Helius Medical Technologies Inc Class A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Helius Medical Technologies Inc Class A to the Medical Devices industry mean.
  • -66.0% Return on Assets means that Helius Medical Technologies Inc Class A generated $-0.66 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Helius Medical Technologies Inc Class A:

  • The MRQ is -66.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -35.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-66.0%TTM-35.4%-30.6%
TTM-35.4%YOY-26.5%-8.8%
TTM-35.4%5Y-37.0%+1.7%
5Y-37.0%10Y-40.1%+3.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.0%-2.1%-63.9%
TTM-35.4%-3.2%-32.2%
YOY-26.5%-4.0%-22.5%
5Y-37.0%-3.1%-33.9%
10Y-40.1%-4.1%-36.0%
4.3.1.3. Return on Equity

Shows how efficient Helius Medical Technologies Inc Class A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Helius Medical Technologies Inc Class A to the Medical Devices industry mean.
  • -97.0% Return on Equity means Helius Medical Technologies Inc Class A generated $-0.97 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Helius Medical Technologies Inc Class A:

  • The MRQ is -97.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -73.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-97.0%TTM-73.4%-23.6%
TTM-73.4%YOY-65.8%-7.6%
TTM-73.4%5Y-65.6%-7.8%
5Y-65.6%10Y-76.5%+10.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-97.0%-2.4%-94.6%
TTM-73.4%-3.9%-69.5%
YOY-65.8%-4.5%-61.3%
5Y-65.6%-4.3%-61.3%
10Y-76.5%-5.6%-70.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Helius Medical Technologies Inc Class A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Helius Medical Technologies Inc Class A is operating .

  • Measures how much profit Helius Medical Technologies Inc Class A makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Helius Medical Technologies Inc Class A to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Helius Medical Technologies Inc Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,503.0%+1,503.0%
TTM-1,503.0%YOY-2,026.9%+523.9%
TTM-1,503.0%5Y-2,641.4%+1,138.4%
5Y-2,641.4%10Y-1,557.5%-1,083.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.9%+12.9%
TTM-1,503.0%-18.2%-1,484.8%
YOY-2,026.9%-13.9%-2,013.0%
5Y-2,641.4%-16.3%-2,625.1%
10Y-1,557.5%-22.1%-1,535.4%
4.3.2.2. Operating Ratio

Measures how efficient Helius Medical Technologies Inc Class A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 80.67 means that the operating costs are $80.67 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Helius Medical Technologies Inc Class A:

  • The MRQ is 80.667. The company is inefficient in keeping operating costs low. -1
  • The TTM is 35.915. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ80.667TTM35.915+44.752
TTM35.915YOY20.325+15.590
TTM35.9155Y31.161+4.754
5Y31.16110Y17.444+13.717
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ80.6671.254+79.413
TTM35.9151.324+34.591
YOY20.3251.326+18.999
5Y31.1611.373+29.788
10Y17.4441.314+16.130
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Helius Medical Technologies Inc Class A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Helius Medical Technologies Inc Class A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.61 means the company has $3.61 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Helius Medical Technologies Inc Class A:

  • The MRQ is 3.614. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.795. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.614TTM3.795-0.181
TTM3.795YOY7.124-3.329
TTM3.7955Y4.638-0.843
5Y4.63810Y2.986+1.652
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6142.550+1.064
TTM3.7952.691+1.104
YOY7.1242.922+4.202
5Y4.6383.415+1.223
10Y2.9863.527-0.541
4.4.3.2. Quick Ratio

Measures if Helius Medical Technologies Inc Class A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Helius Medical Technologies Inc Class A to the Medical Devices industry mean.
  • A Quick Ratio of 2.67 means the company can pay off $2.67 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Helius Medical Technologies Inc Class A:

  • The MRQ is 2.668. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.964. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.668TTM2.964-0.295
TTM2.964YOY6.169-3.206
TTM2.9645Y3.921-0.957
5Y3.92110Y2.562+1.358
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6681.455+1.213
TTM2.9641.674+1.290
YOY6.1691.875+4.294
5Y3.9212.330+1.591
10Y2.5622.555+0.007
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Helius Medical Technologies Inc Class A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Helius Medical Technologies Inc Class A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Helius Medical Technologies Inc Class A to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.32 means that Helius Medical Technologies Inc Class A assets are financed with 32.0% credit (debt) and the remaining percentage (100% - 32.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Helius Medical Technologies Inc Class A:

  • The MRQ is 0.320. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.488. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.320TTM0.488-0.168
TTM0.488YOY0.580-0.092
TTM0.4885Y0.405+0.084
5Y0.40510Y0.880-0.475
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3200.407-0.087
TTM0.4880.397+0.091
YOY0.5800.360+0.220
5Y0.4050.433-0.028
10Y0.8800.457+0.423
4.5.4.2. Debt to Equity Ratio

Measures if Helius Medical Technologies Inc Class A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Helius Medical Technologies Inc Class A to the Medical Devices industry mean.
  • A Debt to Equity ratio of 47.0% means that company has $0.47 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Helius Medical Technologies Inc Class A:

  • The MRQ is 0.470. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.259. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.470TTM1.259-0.789
TTM1.259YOY1.418-0.158
TTM1.2595Y0.832+0.428
5Y0.83210Y1.053-0.221
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4700.552-0.082
TTM1.2590.596+0.663
YOY1.4180.525+0.893
5Y0.8320.630+0.202
10Y1.0530.711+0.342
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Helius Medical Technologies Inc Class A generates.

  • Above 15 is considered overpriced but always compare Helius Medical Technologies Inc Class A to the Medical Devices industry mean.
  • A PE ratio of -0.14 means the investor is paying $-0.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Helius Medical Technologies Inc Class A:

  • The EOD is -0.155. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.142. Based on the earnings, the company is expensive. -2
  • The TTM is -2.409. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.155MRQ-0.142-0.013
MRQ-0.142TTM-2.409+2.266
TTM-2.409YOY-0.654-1.755
TTM-2.4095Y-1.261-1.148
5Y-1.26110Y-1.174-0.087
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.155-1.133+0.978
MRQ-0.142-1.442+1.300
TTM-2.409-2.000-0.409
YOY-0.654-2.111+1.457
5Y-1.261-1.922+0.661
10Y-1.174-2.040+0.866
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Helius Medical Technologies Inc Class A:

  • The EOD is -0.206. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.189. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.439. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.206MRQ-0.189-0.017
MRQ-0.189TTM-1.439+1.249
TTM-1.439YOY-0.928-0.510
TTM-1.4395Y-1.295-0.144
5Y-1.29510Y-1.122-0.173
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.206-1.367+1.161
MRQ-0.189-1.829+1.640
TTM-1.439-2.190+0.751
YOY-0.928-5.489+4.561
5Y-1.295-3.987+2.692
10Y-1.122-4.828+3.706
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Helius Medical Technologies Inc Class A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.55 means the investor is paying $0.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Helius Medical Technologies Inc Class A:

  • The EOD is 0.602. Based on the equity, the company is cheap. +2
  • The MRQ is 0.553. Based on the equity, the company is cheap. +2
  • The TTM is 5.959. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD0.602MRQ0.553+0.049
MRQ0.553TTM5.959-5.407
TTM5.959YOY2.917+3.042
TTM5.9595Y3.228+2.731
5Y3.22810Y-3.441+6.669
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.6022.190-1.588
MRQ0.5532.142-1.589
TTM5.9592.358+3.601
YOY2.9173.005-0.088
5Y3.2284.156-0.928
10Y-3.4414.646-8.087
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Helius Medical Technologies Inc Class A.

4.8.1. Institutions holding Helius Medical Technologies Inc Class A

Institutions are holding 5.87% of the shares of Helius Medical Technologies Inc Class A.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Armistice Capital, LLC3.63510.00161300001300000
2024-06-30Susquehanna International Group, LLP0.4547016260162600
2024-06-30Geode Capital Management, LLC0.4085014610146100
2024-06-30Vanguard Group Inc0.352301259800
2024-06-30Tower Research Capital LLC0.19310.000169045902589.022
2024-06-30UBS Group AG0.04330154915490
2024-06-30CoreCap Advisors, LLC0.0056020000
2024-06-30Advisor Group Holdings, Inc.0.0022080-4-4.7619
2024-06-30Federation des caisses Desjardins du Quebec0.00103700
2024-06-30Bank of America Corp0.0006020200
2024-06-30Morgan Stanley - Brokerage Accounts0.00020800
2024-06-30The Toronto-Dominion Bank0.00020700
2024-09-30St Germain D J Co Inc0.00010200
2024-06-30Wells Fargo & Co000-6-100
Total 5.09690.0017182275+168331+92.4%

4.9.2. Funds holding Helius Medical Technologies Inc Class A

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Fidelity Extended Market Index0.474016951338724.9705
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr0.352301259800
2024-09-30Fidelity Series Total Market Index0.0224080000
2024-09-30Northern Trust Extended Eq Market Idx0.0167059600
2024-09-30NT Ext Equity Mkt Idx Fd - L0.0167059600
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.0107038200
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0086030810.3257
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.002609200
2024-09-30BNYM Mellon SL Market Completion UC10.00010200
2024-10-31State St US Extended Mkt Indx NL Cl C001-1-50
Total 0.9041032326+3387+10.5%

5.3. Insider Transactions

Insiders are holding 0.527% of the shares of Helius Medical Technologies Inc Class A.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-14Dane AndreeffBUY50008.1
2023-11-30Dane AndreeffBUY20006.37
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets5,585
Total Liabilities1,786
Total Stockholder Equity3,799
 As reported
Total Liabilities 1,786
Total Stockholder Equity+ 3,799
Total Assets = 5,585

Assets

Total Assets5,585
Total Current Assets5,406
Long-term Assets179
Total Current Assets
Cash And Cash Equivalents 3,468
Net Receivables 524
Inventory 774
Other Current Assets 640
Total Current Assets  (as reported)5,406
Total Current Assets  (calculated)5,406
+/-0
Long-term Assets
Property Plant Equipment 177
Intangible Assets 2
Long-term Assets  (as reported)179
Long-term Assets  (calculated)179
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,496
Long-term Liabilities290
Total Stockholder Equity3,799
Total Current Liabilities
Short-term Debt 23
Accounts payable 743
Other Current Liabilities 688
Total Current Liabilities  (as reported)1,496
Total Current Liabilities  (calculated)1,454
+/- 42
Long-term Liabilities
Long-term Liabilities  (as reported)290
Long-term Liabilities  (calculated)0
+/- 290
Total Stockholder Equity
Common Stock4
Retained Earnings -167,771
Accumulated Other Comprehensive Income -427
Other Stockholders Equity 171,993
Total Stockholder Equity (as reported)3,799
Total Stockholder Equity (calculated)3,799
+/-0
Other
Cash and Short Term Investments 3,468
Common Stock Shares Outstanding 3,741
Current Deferred Revenue42
Liabilities and Stockholders Equity 5,585
Net Debt -3,445
Net Working Capital 3,910
Short Long Term Debt Total 23



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-30
> Total Assets 
0
0
0
0
7,446
5,391
3,366
1,216
1,430
719
5,255
4,041
9,096
6,802
3,450
8,599
8,629
3,754
6,809
5,663
17,085
13,311
27,827
22,498
18,197
12,880
10,347
8,461
8,704
6,026
6,547
14,664
10,717
7,879
14,102
9,618
6,546
18,859
17,287
13,755
10,753
8,854
7,692
5,757
8,846
5,585
5,5858,8465,7577,6928,85410,75313,75517,28718,8596,5469,61814,1027,87910,71714,6646,5476,0268,7048,46110,34712,88018,19722,49827,82713,31117,0855,6636,8093,7548,6298,5993,4506,8029,0964,0415,2557191,4301,2163,3665,3917,4460000
   > Total Current Assets 
0
0
0
0
7,446
5,391
3,366
1,216
1,430
719
5,255
4,041
9,096
6,802
3,450
8,581
8,496
3,562
6,618
5,455
16,717
12,735
26,961
20,831
16,529
11,228
7,241
5,875
6,743
4,136
4,685
12,863
8,985
6,238
12,594
8,026
5,064
18,217
16,697
13,209
10,265
8,576
7,298
5,486
8,641
5,406
5,4068,6415,4867,2988,57610,26513,20916,69718,2175,0648,02612,5946,2388,98512,8634,6854,1366,7435,8757,24111,22816,52920,83126,96112,73516,7175,4556,6183,5628,4968,5813,4506,8029,0964,0415,2557191,4301,2163,3665,3917,4460000
       Cash And Cash Equivalents 
0
0
0
0
7,030
5,000
2,906
419
972
192
4,350
2,644
7,973
6,173
2,669
7,666
6,859
2,617
5,562
4,395
15,987
12,397
25,583
18,656
14,311
9,019
5,459
4,360
5,264
2,680
3,331
11,397
7,425
4,700
11,005
6,310
3,273
16,658
14,549
11,340
8,599
6,596
5,182
3,638
6,387
3,468
3,4686,3873,6385,1826,5968,59911,34014,54916,6583,2736,31011,0054,7007,42511,3973,3312,6805,2644,3605,4599,01914,31118,65625,58312,39715,9874,3955,5622,6176,8597,6662,6696,1737,9732,6444,3501929724192,9065,0007,0300000
       Short-term Investments 
0
0
0
0
0
0
0
378
378
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000003783780000000
       Net Receivables 
0
0
0
0
1
2
4
9
24
116
122
399
532
170
225
575
1,288
755
704
697
530
41
275
1,092
1,014
758
574
234
194
218
230
203
220
198
251
245
196
217
343
167
185
566
637
562
659
524
5246595626375661851673432171962452511982202032302181942345747581,0141,092275415306977047551,2885752251705323991221162494210000
       Other Current Assets 
0
0
0
300
415
390
456
411
434
411
784
998
590
459
556
340
349
190
352
105
200
100
711
352
302
162
610
687
715
666
735
779
833
802
862
951
1,018
733
1,216
1,085
918
893
1,022
902
767
640
6407679021,0228939181,0851,2167331,018951862802833779735666715687610162302352711100200105352190349340556459590998784411434411456390415300000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
133
192
191
208
368
576
866
1,667
1,668
1,652
3,106
2,586
1,961
1,890
1,862
1,801
1,732
1,641
1,508
1,592
1,482
642
590
546
488
278
394
271
205
179
1792052713942784885465906421,4821,5921,5081,6411,7321,8011,8621,8901,9612,5863,1061,6521,6681,66786657636820819119213318000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115
174
173
190
350
558
554
1,343
1,330
1,311
1,264
1,195
595
568
576
553
511
498
412
520
493
464
450
445
423
247
230
216
196
177
1771962162302474234454504644935204124985115535765685951,1951,2641,3111,3301,3435545583501901731741150000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,242
686
710
725
759
769
783
762
763
777
753
0
0
0
0
0
0
0
0
0
0000000007537777637627837697597257106861,24200000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
582
687
638
579
527
479
438
381
333
291
236
178
140
101
65
31
24
17
9
2
291724316510114017823629133338143847952757963868758200000000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
18
18
18
18
18
18
312
324
338
341
18
18
18
18
1,376
1,324
1,283
0
0
4
-1,482
-642
-590
-546
-488
0
140
38
7
0
07381400-488-546-590-642-1,4824001,2831,3241,3761818181834133832431218181818181818000000000000000
> Total Liabilities 
0
0
0
584
859
1,169
1,210
2,779
3,430
1,824
7,244
4,057
4,340
4,461
6,894
9,508
8,187
13,903
14,299
7,892
29,138
17,768
17,973
10,480
5,415
4,058
4,512
3,252
2,308
2,829
2,676
2,766
2,350
2,842
2,846
2,488
2,044
5,898
9,136
7,688
6,181
5,833
5,342
3,771
2,507
1,786
1,7862,5073,7715,3425,8336,1817,6889,1365,8982,0442,4882,8462,8422,3502,7662,6762,8292,3083,2524,5124,0585,41510,48017,97317,76829,1387,89214,29913,9038,1879,5086,8944,4614,3404,0577,2441,8243,4302,7791,2101,169859584000
   > Total Current Liabilities 
0
0
0
584
859
1,169
1,210
1,198
1,583
1,462
6,414
2,331
4,340
4,461
6,894
9,508
8,187
13,903
14,299
7,892
29,138
17,768
17,973
9,883
4,861
3,547
3,802
2,617
2,027
2,565
2,424
2,534
2,137
2,642
2,653
2,199
1,777
1,200
1,988
1,789
1,524
1,435
1,879
1,576
2,057
1,496
1,4962,0571,5761,8791,4351,5241,7891,9881,2001,7772,1992,6532,6422,1372,5342,4242,5652,0272,6173,8023,5474,8619,88317,97317,76829,1387,89214,29913,9038,1879,5086,8944,4614,3402,3316,4141,4621,5831,1981,2101,169859584000
       Short-term Debt 
0
0
0
368
0
0
0
0
0
200
0
0
200
3,015
4,474
4,990
3,966
9,926
1,009
1,279
11,769
1,071
13,769
148
156
164
172
180
154
107
59
61
62
47
3
51
52
53
54
51
49
47
90
46
70
23
237046904749515453525134762615910715418017216415614813,7691,07111,7691,2791,0099,9263,9664,9904,4743,0152000020000000368000
       Short Long Term Debt 
0
0
0
368
0
0
0
0
0
0
0
0
3,303
3,015
4,474
4,990
3,966
9,926
9,578
3,807
0
0
0
148
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001480003,8079,5789,9263,9664,9904,4743,0153,30300000000368000
       Accounts payable 
0
0
0
216
859
1,169
1,210
1,198
1,583
1,141
1,414
2,181
1,141
1,414
2,161
4,518
3,826
3,637
3,479
2,573
1,521
2,186
2,392
2,474
3,047
1,714
1,676
1,111
456
720
747
1,093
912
1,067
1,069
1,111
1,043
570
627
840
576
497
531
814
1,287
743
7431,2878145314975768406275701,0431,1111,0691,0679121,0937477204561,1111,6761,7143,0472,4742,3922,1861,5212,5733,4793,6373,8264,5182,1611,4141,1412,1811,4141,1411,5831,1981,2101,169859216000
       Other Current Liabilities 
0
0
0
0
859
1,169
1,210
1,198
1,583
1,262
6,414
2,331
2,999
3,048
4,733
4,990
4,361
10,266
9,578
3,807
15,615
14,278
15,581
5,743
282
83
1,524
1,005
1,085
1,399
1,337
1,096
873
1,276
1,433
1,008
654
551
1,280
856
856
849
1,047
624
639
688
6886396241,0478498568561,2805516541,0081,4331,2768731,0961,3371,3991,0851,0051,524832825,74315,58114,27815,6153,8079,57810,2664,3614,9904,7333,0482,9992,3316,4141,2621,5831,1981,2101,1698590000
   > Long-term Liabilities 
0
0
0
0
0
0
0
1,581
1,846
362
830
1,726
1,726
0
2,161
0
3,826
3,637
3,712
2,806
1,754
2,419
2,392
597
554
511
710
635
281
264
252
232
213
200
193
289
267
4,698
7,148
5,899
4,657
4,398
3,463
2,195
450
290
2904502,1953,4634,3984,6575,8997,1484,6982672891932002132322522642816357105115545972,3922,4191,7542,8063,7123,6373,82602,16101,7261,7268303621,8461,5810000000
       Other Liabilities 
0
0
0
0
0
0
0
1,581
2,256
397
897
1,726
0
0
0
0
0
0
0
0
0
0
0
0
0
0
245
218
219
217
220
216
213
200
193
190
184
4,628
7,092
0
4,622
0
0
0
0
0
000004,62207,0924,628184190193200213216220217219218245000000000000001,7268973972,2561,5810000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
1,581
2,255
398
898
1,726
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,622
0
0
0
0
0
000004,62200000000000000000000000000001,7268983982,2551,5810000000
> Total Stockholder Equity
-8
0
0
0
6,588
4,223
2,156
-1,563
-1,999
-1,105
-1,988
-16
4,756
2,341
-3,444
-909
442
-10,149
-7,490
-2,229
-12,053
-4,457
9,854
12,018
12,782
8,822
5,835
5,209
6,396
3,197
3,871
11,898
8,367
5,037
11,256
7,130
4,502
12,961
8,151
6,067
4,572
3,021
2,350
1,986
6,339
3,799
3,7996,3391,9862,3503,0214,5726,0678,15112,9614,5027,13011,2565,0378,36711,8983,8713,1976,3965,2095,8358,82212,78212,0189,854-4,457-12,053-2,229-7,490-10,149442-909-3,4442,3414,756-16-1,988-1,105-1,999-1,5632,1564,2236,588000-8
   Common Stock
0
0
0
0
20,849
20,849
20,849
16,358
18,792
19,109
20,658
24,348
30,570
30,897
30,897
38,845
45,086
45,917
52,230
59,229
70,512
23
26
26
26
26
31
38
45
45
1
2
2
2
4
4
4
28
28
28
28
1
1
1
3
4
4311128282828444222145453831262626262370,51259,22952,23045,91745,08638,84530,89730,89730,57024,34820,65819,10918,79216,35820,84920,84920,8490000
   Retained Earnings Total Equity00000-155,2490000000-128,246-122,265-118,903-116,368-112,891-109,530-104,773-99,442-93,854-93,668-94,992-89,877-85,360-67,534-66,369-62,640-49,702-44,0230-32,376-29,390-26,305-22,475-20,043-21,828-19,4230000000
   Accumulated Other Comprehensive Income 
-8
0
0
0
106
313
-178
-972
-931
-1,499
-1,862
-999
-1,093
-1,266
-1,728
-1,732
-1,078
188
47
-906
-787
-883
-591
-703
-827
-759
-902
-266
-521
-693
-1,099
-1,227
-1,412
-1,125
-1,125
-1,327
-976
-232
-388
-383
-650
-459
-673
-385
-245
-427
-427-245-385-673-459-650-383-388-232-976-1,327-1,125-1,125-1,412-1,227-1,099-693-521-266-902-759-827-703-591-883-787-90647188-1,078-1,732-1,728-1,266-1,093-999-1,862-1,499-931-972-178313106000-8
   Capital Surplus 
0
0
0
0
0
0
0
2,435
2,054
1,824
2,155
2,941
4,669
5,085
0
6,001
6,136
6,386
6,602
6,982
3,582
86,280
105,411
106,363
107,437
108,997
111,479
114,967
119,763
120,213
123,872
135,388
138,023
0
0
0
0
0
0
0
160,443
0
0
0
0
0
00000160,4430000000138,023135,388123,872120,213119,763114,967111,479108,997107,437106,363105,41186,2803,5826,9826,6026,3866,1366,00105,0854,6692,9412,1551,8242,0542,4350000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
9,585
1,403
1,997
3,984
1,530
1,714
1,820
2,176
2,941
4,669
5,085
5,732
6,001
6,136
6,386
6,602
6,982
3,582
86,280
105,411
106,363
107,437
108,997
111,479
114,967
119,763
120,213
123,872
135,388
138,023
139,093
149,412
149,834
150,665
159,386
159,618
160,023
160,443
162,391
162,979
164,843
170,666
171,993
171,993170,666164,843162,979162,391160,443160,023159,618159,386150,665149,834149,412139,093138,023135,388123,872120,213119,763114,967111,479108,997107,437106,363105,41186,2803,5826,9826,6026,3866,1366,0015,7325,0854,6692,9412,1761,8201,7141,5303,9841,9971,4039,585000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.